Early Systemic Inflammatory Response to Drug-Eluting Stents Implantation: The Heart of the Difference?: Editorial to: “Comparison of Changes in Early Inflammatory Markers Between Sirolimus- and Paclitaxel-Eluting Stent Implantation” by Li et al.

By Pires Nuno   Jukema J.  

Cardiovascular Drugs and Therapy, Vol. 23, Iss. 2, 2009-04 ,pp. : 103-105

Springer Publishing Company

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Paclitaxel/sirolimus: Coronary aneurysm following drug-eluting stent implantation in an elderly patient: case report

By  

Reactions Weekly, Vol. 1, Iss. 1168, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Sirolimus- or paclitaxel-eluting stents for coronary artery revascularisation

By Doggrell Sheila A  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 225-228

Informa Healthcare

Access to resources Recommend Favorite

Paclitaxel-eluting stent safe, effective against restenosis

By  

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite